From: Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
 |  | 95% CI |  | ||
---|---|---|---|---|---|
Covariate | Coefficient (bi) | [HR Exp(bi)] | Lower | Upper | P-value |
FIGO stage | Â | Â | Â | Â | <0.001 |
I | (0.000) | (1.00) | Â | Â | Â |
II | −3.064 | .047 | .011 | .192 | <0.001 |
III | −3.025 | .049 | .010 | .233 | <0.001 |
IV | −1.810 | .164 | .040 | .669 | .012 |
WHO grade | Â | Â | Â | Â | .023 |
1 | (0.000) | (1.00) | Â | Â | Â |
2 | −.820 | .440 | .246 | .790 | .006 |
3 | −.561 | .571 | .325 | 1.002 | .051 |
Histology | Â | Â | Â | Â | 0.068 |
Endometrioid | (0.000) | (1.00) | Â | Â | Â |
Serous | −.297 | .743 | .233 | 2.372 | .616 |
Clear cell | −.069 | .934 | .260 | 3.349 | .916 |
Mucinous | −1.423 | .241 | .024 | 2.403 | .225 |
Squamous cell | .074 | 1.077 | .260 | 4.470 | .918 |
Mixed cell | 3.167 | 23.742 | 2.245 | 251.079 | .008 |
Undifferentiated | −.163 | .850 | .255 | 2.828 | .790 |
Lymph node metastasis | −.732 | .481 | .209 | 1.109 | .086 |
Age (≤50 y vs. >50 y) | 1.939 | 6.953 | .909 | 53.204 | .062 |
Diabetes | .451 | 1.570 | .880 | 2.800 | .127 |
Obesity | −.065 | .937 | .600 | 1.462 | .774 |
Hypertension | .454 | 1.575 | 1.043 | 2.380 | .031 |
Lymphangiosis | .216 | 1.241 | .631 | 2.443 | .532 |
Hemangiosis | .681 | 1.975 | .476 | 8.187 | .348 |
ER alpha | −.031 | .970 | .652 | 1.442 | .880 |
PRA | −.156 | .855 | .572 | 1.279 | .446 |
GdA | .840 | 2.317 | 1.362 | 3.943 | .002 |
Gd | −.298 | .743 | .456 | 1.209 | .232 |